Zitter Health Insights Access Answered.

Managed Markets Insights

Perspectives on Medical Therapy Access, Reimbursement and Payer Influences

Doctor Communication and Medication Adherence

A recent large-scale survey found that people living with rheumatoid arthritis (RA) believe that their relationship with their healthcare professional can positively impact the management of their disease.[i] But how does doctor-patient communications influence the patient’s adherence to medication protocols? Our December 2015 Abandonment …

Read Post

Hassle Factor-How Do Therapeutic Areas Differ?

The U.S. healthcare system incurs more than $200 billion in avoidable costs every year, and much of this staggering number is attributed to prescription abandonment and non-adherence to recommended drug therapies.1 Simply put, patients who do not fill their prescriptions cannot take the medications …

Read Post

The benefits of being the fly on the wall

Our pharmaceutical customers invest months — sometimes years — and massive resources in preparing a new drug or health technology for market launch.  Both those launching a product and those carefully watching a competitive launch have questions about how the product’s value proposition will …

Read Post

PCSK9 Inhibitors: A New Class of LDL-C Lowering Treatments

Since their development in the late 1980s, Statins have remained the gold standard in treating and regulating cholesterol production. Blockbuster drugs such as Lipitor (atorvastatin) and Crestor (rosuvastatin) produced annual revenues of over $12B globally in the mid-2000s. However, this blog post will discuss …

Read Post

Co-pay discount programs still in the cards

Despite the backlash amongst health plans and pharmacy benefit managers (PBMs) when co-pay cards first arrived on the managed markets scene, discount programs are still a frequently cited topic during payer visits, according to Zitter Health Insight’s ongoing research on value added programs. Co-pay …

Read Post